spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Biopharmaceuticals company attends sector conferences in the online format

3P Biopharmaceuticals




A leading Contract Development and Manufacturing Organization (CDMO), 3P Biopharmaceuticals, specialized in process development and cGMP manufacturing of biologics, is attending the most relevant events of the sector, although in digital format, as a consequence of the cancellation of global events due to the pandemic.

COVID19 has affected everyone and all sectors. Therefore, events and conferences in the pharma and biotech sectors have also been affected. So, meanwhile, some events are postponed, others are cancelled but others are switched to digital format. This is the best way to cover the cancellation of the fairs and to be able to continue with the commercial activity.

Covid19 Virtual Partnering Event, held this year between May 4 and 6, as a platform for pharma and biotech companies to share their proposals and projects in the fight against COVID. This is the first year that 3P has participated in a virtual event and the cause deserved it. Although according to Elena Erroba, Business Development Director: " We had interesting meetings and we have to follow the evolution of the relationships with the companies identified in this event, although it is true that being at the conference face to face favours a fluid conversation and the mutual knowledge of the potential of future collaboration and in this digital format this interaction and closeness is missing".

BIO International Convention (this year BIO DIGITAL) is the leading conference of the biotech sector worldwide and one of the annual must-attend events for 3P. It is held in the United States and this year was planned to take place in San Diego in June 8-12. This is the first year that the company was going to attend as its exhibitor with a 10sqm stand but after the circumstances, it will be held in digital format. In the words of Erroba: "Attendance in digital format is the best possible solution after the cancellation or suspension of the fairs, events and other face-to-face activities we have attended up to now. It is not the same as having a booth and meetings in person but we hope to have promising meetings since this fair has always been a key element in getting to know a highly demanding market such as the American one, as well as consolidating long term relationships with companies from all over the world. "

With almost its entire portfolio composed of international clients, 3P has an active presence in the main international markets such as the United States, Germany, France, Sweden, Norway, Italy, the United Kingdom, Belgium, Switzerland, Australia, etc. Therefore, attendance at international fairs is a key part of their business strategy. Besides, according to Elena Erroba, "the conferences we attend are an essential showcase to promote interaction with clients, potential clients, companies and to consolidate our image in the international marketplace".

Other affected conferences

Bio Europe Spring was also held in digital format in March and Bio Trinity in April. But other events such as Swiss Biotech Days, Antibody Industrial Symposium or Bio Spain are some of the international events that 3P has attended during the last few years and that time have been postponed to the end of the year or even to 2021. However, Bio Europe or CPhI, scheduled for the autumn, have not yet announced any changes to the planned agenda. In any case, we will have to see how the pandemic evolves to see how the sector's fairs develop.

About 3P Biopharmaceuticals

3P Biopharmaceuticals is a leading CDMO specialized in process development and GMP manufacturing of biologics and cell therapy products. 3P offers solutions at all stages of biologics development, from initial process and analytics development to preclinical and clinical phases and commercial production. Its extensive experience, flexibility, and adaptation, as well as its innovative technology and qualified team, have made 3P an example for the international market.

For further information: http://www.3pbio.com/
web https://www.3pbio.com/
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Biopharmaceuticals company attends sector conferences in the online format

A leading Contract Development and Manufacturing Organization (CDMO), 3P Biopharmaceuticals, specialized in process development and cGMP manufacturing of biologics, is attending the most relevant events of the sector, although in digital format, as a consequence of the cancellation of global events due to the pandemic. COVID19 has affected everyone and all sectors.
More info >>


White Papers

Microalgae Culture Using the DASGIP® PBR4 Module for Illumination with a New Brunswick™ CelliGen® 310 Stirred-tank Bioreactor

Eppendorf

The number of bioprocess applications for microalgae has increased in recent years, particularly in the fi eld of biofuel production. The combination of the New Brunswick CelliGen 310 stirred-tank bioreactor and the DASGIP LED Illumination System creates a bioreactor setup which is capable of supporting high density microalgal growth. Using the stand-alone Eppendorf DASGIP PBR4 Module, LED illumination spectra and intensities can be controlled for optimal support of all types of chlorophylls and carotenoids. For this study in which high density culture of up to 1.5 x 107 cells/mL was achieved, the unicellular freshwater alga, Dunaliella tertiolecta, was used.
More info >>

Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement